Heart Attack and Kidney Disease - Cardiovascular Update

Research shows sotagliflozin is the first medication of its kind to significantly reduce both heart attacks and strokes

Medical Xpress - Cardiology

FEBRUARY 14, 2025

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart attack and stroke among these patients, according to results from an international clinical trial led by a Mount Sinai researcher.

Heart Attack

Heart Attack Heart attacks Research Kidney Disease

SGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney Disease

Med Page Today

FEBRUARY 14, 2025

(MedPage Today) -- The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk patients with type 2 diabetes (T2D), chronic kidney disease (CKD), and cardiovascular risk factors, a prespecified.

Kidney Disease

Kidney Disease Heart attacks Heart Attack Diabetes

SGLT-2 Inhibitors Show Mixed Results After Heart Attack

DAIC

APRIL 6, 2024

However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heart attack. The study enrolled 6,522 people treated for acute myocardial infarction at 451 centers in 22 countries. About 32% had Type 2 diabetes.

Heart attacks

Heart attacks Heart Attack Heart Failure Outpatient

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes

Science Daily - Heart Disease

FEBRUARY 14, 2025

New research shows sotagliflozin is the only drug in its class to demonstrate these results.

Heart attacks

Heart attacks Heart Attack Kidney Disease Heart Failure

EMPACT-MI Trial Outcomes Reported at ACC24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack

DAIC

APRIL 6, 2024

While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack, according to results from the EMPACT-MI trial presented on day one of the American College of Cardiology Scientific Sessions, ACC.24,

Heart Attack

Heart Attack Heart attacks Heart Failure Outcomes

How High Blood Pressure Affects Your Heart and What You Can Do About It

MIBHS

FEBRUARY 15, 2025

Secondary hypertension : This type results from an underlying condition such as kidney disease, hormonal disorders, or the use of certain medications. The Link Between High Blood Pressure and Heart Health Your heart and blood vessels form a complex network that ensures oxygen and nutrients reach every part of your body.

Blood Pressure

Blood Pressure Hypertension Chest Pain Aneurysm

Is Anemia Common After Heart Bypass Surgery?

MIBHS

DECEMBER 27, 2024

This condition occurs when the blood vessels that supply blood to the heart become blocked or narrowed by plaque buildup. As a result, the heart doesnt receive enough oxygen-rich blood, which can lead to chest pain, shortness of breath, or even a heart attack.

Coronary Artery Bypass Graft

Coronary Artery Bypass Graft Open-Heart Surgery Kidney Disease Chronic Disease

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease

One Injection of Novel Drug Cuts Systolic Blood Pressure by Up to 12 mmHg

DAIC

APRIL 7, 2024

High blood pressure, or hypertension , is a leading cause of heart attacks, strokes and death. It occurs when the heart has to work harder to push blood through the blood vessels, increasing pressure inside the vessels. Centers for Disease Control and Prevention (CDC) estimates that nearly half of U.S.

Blood Pressure

Blood Pressure Heart Attack Heart attacks Hypertension

Why Your Blood Pressure Probably Isn't Normal & What You Need To Do About It.

Dr. Paddy Barrett

JULY 5, 2024

And if it’s not, your risk of: Heart disease. Heart attack. Kidney disease. For every 20 mmHg increase in systolic blood pressure above normal, the risk of dying from a heart attack or stroke doubles 3. But odds are, your blood pressure should be in this range. Dementia An early death.

Blood Pressure

Blood Pressure Heart Attack Heart attacks Risk Factors

Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients

DAIC

JANUARY 19, 2024

This leaves a gap in the care of these patients and increases their risk for heart attack, stroke and heart failure progression. HTN accelerates the progression of atherosclerosis and leads to increased risk of major cardiac events like heart attack, heart failure, kidney disease and other end organ damage.

Pacemaker

Pacemaker Hypertension Blood Pressure Kidney Disease

New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies

DAIC

MAY 16, 2024

A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).

Peripheral Arterial Disease

Peripheral Arterial Disease Exercise Ischemia Quality of Life

Research shows sotagliflozin is the first medication of its kind to significantly reduce both heart attacks and strokes

SGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney Disease

SGLT-2 Inhibitors Show Mixed Results After Heart Attack

Webinars

A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes

EMPACT-MI Trial Outcomes Reported at ACC24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack

How High Blood Pressure Affects Your Heart and What You Can Do About It

Is Anemia Common After Heart Bypass Surgery?

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

One Injection of Novel Drug Cuts Systolic Blood Pressure by Up to 12 mmHg

Why Your Blood Pressure Probably Isn't Normal & What You Need To Do About It.

Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients

New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies

Stay Connected